Related Experiment Video
Updated: Sep 28, 2025

11:28
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
8.6K
Cancer Stem Cell Markers for Urinary Carcinoma
Pu Xia1, Da-Hua Liu1, Ze-Jun Xu1
1Biological Anthropology Institute, Liaoning Medical University, Jinzhou, Liaoning, China.
Stem Cells International
|March 28, 2022
Summary
Cancer stem cells (CSCs) drive tumor recurrence and metastasis. Identifying specific CSC markers in the urinary system is crucial for developing targeted cancer therapies and overcoming drug resistance.
Area of Science:
- Oncology
- Stem Cell Biology
- Urology
Background:
- Cancer stem cells (CSCs) possess self-renewal and differentiation capabilities, contributing to tumor recurrence and metastasis.
- CSCs are difficult to detect and target with conventional therapies due to their low abundance and inherent resistance.
- Current methods for isolating and identifying CSCs from solid tumors are limited by the lack of specific molecular markers.
Purpose of the Study:
- To review and summarize known cancer stem cell surface and functional markers within the urinary system.
- To highlight the importance of these markers as potential targets for novel cancer therapies.
- To address the challenges in CSC isolation and identification.
Main Methods:
- Comprehensive literature review of studies identifying CSC markers in urinary system cancers.
- Analysis of reported surface and functional markers associated with CSCs.
- Synthesis of information on marker utility in diagnosis and therapy.
Main Results:
- Identification of various surface and functional markers specific to CSCs in urinary system tumors.
- Discussion of the role of these markers in CSC self-renewal, differentiation, and drug resistance.
- Highlighting the potential of these markers for therapeutic targeting.
Conclusions:
- Specific molecular markers are essential for the isolation, identification, and therapeutic targeting of CSCs in urinary system cancers.
- Targeting these CSC markers offers a promising strategy to combat cancer recurrence, metastasis, and treatment resistance.
- Further research into CSC markers will advance the development of more effective urinary cancer therapies.
More Related Videos
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
3.6K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.6K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K

